Related Experiment Videos
MRI characteristics of chondroblastoma
1MRI Centre, Royal Orthopaedic Hospital, Birmingham, UK.
Clinical Radiology
|January 1, 1996
Summary
Magnetic resonance (MR) imaging effectively characterizes chondroblastoma, revealing a low signal intensity rim and internal calcifications. Edema patterns on MR imaging may indicate tumor activity in chondroblastoma recurrence.
Area of Science:
- Orthopedic Oncology
- Radiology
- Medical Imaging
Background:
- Chondroblastoma is a rare bone tumor typically affecting the epiphysis of long bones.
- Accurate imaging is crucial for diagnosis, staging, and monitoring treatment response.
- Magnetic resonance (MR) imaging offers detailed soft tissue and bone marrow visualization.
Purpose of the Study:
- To evaluate the utility of MR imaging in characterizing chondroblastoma at initial presentation and recurrence.
- To correlate MR imaging findings with histological confirmation and clinical outcomes.
Main Methods:
- Retrospective analysis of MR imaging in 16 patients with histologically proven chondroblastoma.
- Review of imaging features including signal intensity, presence of edema, and joint effusion.
- Correlation of MR findings with radiographic and CT findings, and subsequent histology for suspected recurrences.
Main Results:
- Primary chondroblastomas exhibited a lobulated low signal intensity rim on MR imaging.
- Internal low signal intensity foci, indicative of calcification, were present in 11/12 primary cases.
- Bone marrow edema (11/12) and joint effusion (8/12) were common findings in primary tumors.
- The STIR sequence effectively delineated edema.
- Peritumoral edema on MR imaging correlated with histologically confirmed recurrence in one case.
Conclusions:
- MR imaging is valuable for diagnosing chondroblastoma, showing characteristic imaging features.
- The presence and extent of bone marrow and soft tissue edema may serve as an indicator of chondroblastoma activity and recurrence.
- Further research is needed to validate edema as a definitive marker of tumor activity.